UBS O'Connor’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $520K | Sell |
34,761
-21,254
| -38% | -$318K | 0.03% | 246 |
|
|
2025
Q1 | $656K | Buy |
56,015
+23,281
| +71% | +$273K | 0.02% | 197 |
|
|
2024
Q4 | $748K | Buy |
32,734
+23,907
| +271% | +$547K | 0.02% | 246 |
|
|
2024
Q3 | $370K | Buy |
8,827
+1,727
| +24% | +$72.5K | 0.01% | 346 |
|
|
2024
Q2 | $258K | Buy |
+7,100
| New | +$258K | 0.01% | 387 |
|